Trulieve Cannabis Corp.
TRLV · XNYSCIK 1754195fmd_1799SEB2YH2ZR370VCJ068Q34JManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2018 to Sep 30, 2026, 29 periods
Latest annual · FY2025
Millions- Total revenues
- 1,181
- Gross profit
- 711
- Operating income
- 143
- Net income
- (122)
- Free cash flow
- 229
Latest quarter · Q3 FY2026
Millions- Total revenues
- 230
- Gross profit
- 148
- Operating income
- 42
- Net income
- 1
- Free cash flow
- 32
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- -1.0%
- Revenue, 5 yearsFY2020 to FY2025
- +17.8%
- Net income, 5 yearsFY2020 to FY2025
- n/m
Trulieve Cannabis Corp. (TRLV) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $1.2 billion | $1.2 billion | -0.4% | 10-K 2026-02-26 · proof |
| Gross profit | $711.2 million | $715.7 million | -0.6% | 10-K 2026-02-26 · proof |
| Operating income | $143.5 million | $97.8 million | +46.8% | 10-K 2026-02-26 · proof |
| Net income | -$122.2 million | -$160.6 million | 10-K 2026-02-26 · proof | |
| Cash from operating activities | $272.8 million | $271.5 million | +0.5% | 10-K 2026-02-26 · proof |
| Free cash flow | $228.6 million | $148.9 million | +53.6% | 10-K 2026-02-26 · proof |
| Total assets | $2.7 billion | $2.9 billion | -6.1% | 10-K 2026-02-26 · proof |
| Total liabilities | $1.6 billion | $1.6 billion | -4.2% | 10-K 2026-02-26 · proof |
| Cash and cash equivalents | $255.5 million | $238.8 million | +7% | 10-K 2026-02-26 · proof |
- What was Trulieve Cannabis Corp. (TRLV)'s revenue in fiscal 2025?
- Trulieve Cannabis Corp. (TRLV) reported revenue of $1.2 billion for fiscal 2025 (the year ended Dec 31, 2025), against $1.2 billion the year before (-0.4%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Trulieve Cannabis Corp. (TRLV)'s gross profit in fiscal 2025?
- Trulieve Cannabis Corp. (TRLV) reported gross profit of $711.2 million for fiscal 2025 (the year ended Dec 31, 2025), against $715.7 million the year before (-0.6%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Trulieve Cannabis Corp. (TRLV)'s operating income in fiscal 2025?
- Trulieve Cannabis Corp. (TRLV) reported operating income of $143.5 million for fiscal 2025 (the year ended Dec 31, 2025), against $97.8 million the year before (+46.8%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Trulieve Cannabis Corp. (TRLV)'s net income in fiscal 2025?
- Trulieve Cannabis Corp. (TRLV) reported net income of -$122.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$160.6 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Trulieve Cannabis Corp. (TRLV)'s cash from operating activities in fiscal 2025?
- Trulieve Cannabis Corp. (TRLV) reported cash from operating activities of $272.8 million for fiscal 2025 (the year ended Dec 31, 2025), against $271.5 million the year before (+0.5%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Trulieve Cannabis Corp. (TRLV)'s free cash flow in fiscal 2025?
- Trulieve Cannabis Corp. (TRLV) reported free cash flow of $228.6 million for fiscal 2025 (the year ended Dec 31, 2025), against $148.9 million the year before (+53.6%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What are Trulieve Cannabis Corp. (TRLV)'s total assets?
- As of Dec 31, 2025, Trulieve Cannabis Corp. (TRLV) reported total assets of $2.7 billion, against $2.9 billion a year earlier (-6.1%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What are Trulieve Cannabis Corp. (TRLV)'s total liabilities?
- As of Dec 31, 2025, Trulieve Cannabis Corp. (TRLV) reported total liabilities of $1.6 billion, against $1.6 billion a year earlier (-4.2%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What are Trulieve Cannabis Corp. (TRLV)'s cash and cash equivalents?
- As of Dec 31, 2025, Trulieve Cannabis Corp. (TRLV) reported cash and cash equivalents of $255.5 million, against $238.8 million a year earlier (+7%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:TRLV&period_type=annual&limit=5"Information only, not investment advice.